Multicenter Myocardial Viability Trial

C

CHI St. Luke's Health, Texas

Status

Completed

Conditions

Coronary Artery Disease

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00661232
IND# 66,506
NDA# 20-937
1102-02-777

Details and patient eligibility

About

The purpose of this study is to test the hypothesis of whether contrast enhanced Magnetic Resonance Imaging can be used to predict improvement of the wall motion in regions of the heart with abnormal movement following bypass surgery or percutaneous angioplasty in various institutions across three continents.

Enrollment

235 patients

Sex

All

Ages

21 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: > 21 years and < 85 years
  • Sinus rhythm
  • Weight < 120 kg
  • LVEF > 30%
  • Wall motion abnormality on Echo. or LV-gram
  • Scheduled for revascularization - Angioplasty/Stent or CABG - within 30 days

Exclusion criteria

  • Resting heart rate > 100 bpm
  • Frequent atrial or ventricular ectopy
  • Severe aortic stenosis or HOCM
  • Unstable angina
  • Myocardial infarction within 14 days
  • Active congestive heart failure
  • Pregnancy
  • Known allergy to gadolinium
  • Contraindication to MRI

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems